Curve Therapeutics

Southampton, United Kingdom

Curve develops an innovative screening platform.

$51.4M raised

Feb 2024

Series A

Biotechnology Chemical Pharmaceutical

Top Investors

Columbus Venture Partners Pfizer Venture Investments Epidarex Capital British Patient Capital Advent Life Sciences

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Curve Therapeutics

How much funding has Curve Therapeutics raised?

Curve Therapeutics has raised $51.4M in total funding. The most recent round was Series A. The last funding was announced in February 2024.

Who are Curve Therapeutics's investors?

Curve Therapeutics's investors include Columbus Venture Partners, Pfizer Venture Investments, Epidarex Capital, British Patient Capital, Advent Life Sciences.

Where is Curve Therapeutics headquartered?

Curve Therapeutics is headquartered in Southampton, United Kingdom.

What does Curve Therapeutics do?

Curve develops an innovative screening platform.

What stage is Curve Therapeutics at?

Curve Therapeutics is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated February 27, 2024.

MLA

"Curve Therapeutics — Funding & Investors." VCBacked, February 27, 2024, https://www.vcbacked.co/company/curve-therapeutics. Accessed July 3, 2026.

APA

VCBacked. (2024). Curve Therapeutics — Funding & Investors. Retrieved July 3, 2026, from https://www.vcbacked.co/company/curve-therapeutics

Wikipedia (cite web)

{{cite web |title=Curve Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/curve-therapeutics |website=VCBacked |access-date=July 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated February 27, 2024.